The Division of Hematology-Oncology is internationally recognized for its leadership in the prevention, detection, diagnosis, and treatment of cancer. The Division maintains a close collaboration with UPMC CancerCenter, one of the largest integrated community networks of cancer physicians and health care specialists in the United States, and is expanding internationally. Together, we are highly committed to meeting the highest standards of cancer care and providing the most advanced treatment of all types of cancers and blood-related disorders.
The Division of Hematology/Oncology and UPMC CancerCenter work together to provide compassionate, sophisticated care to cancer patients from the tri-state region and beyond. With its broad network of community cancer physicians and the Hillman Cancer Center serving as its flagship site, UPMC CancerCenter represents the clinical arm of all outpatient and inpatient cancer programs. We offer patients the latest advances in screening, detection, prevention, diagnosis, and treatment for both common and rare cancers. Our multidisciplinary clinical cancer programs provide patients with comprehensive, focused care specific to their type of cancer, and are staffed by nationally and internationally recognized cancer care specialists. In addition, our Biobehavioral Oncology Program (BOP) promotes innovative and productive interdisciplinary research focused on the role of mind and brain in cancer with the long term objective of contributing to reduced risk of cancer development, earlier detection of cancer, improved cancer treatment response, reduced symptom burden, and enhanced survival.
Our faculty are engaged in numerous multidisciplinary tumor board clinics and conferences, ensuring that clinicians are able to collaborate across oncology disciplines, providing the highest quality patient care. This cooperation also allows many patients with malignancies to see all of their oncology specialists in one day.
Reaching into the Community
In addition to onsite patient care programs, the Division’s community network of medical oncologists assist in conducting its numerous clinical trials. This network includes 35 treatment centers in western Pennsylvania and eastern Ohio and treats an additional 12,000 new cancer patients each year beyond what is seen at the Hillman Cancer Center. Cutting-edge treatments, sophisticated technologies, and clinical trials are all available to patients through this integrated network.
Division faculty and UPMC CancerCenter clinicians have developed Via Oncology Pathways, an innovative web-based decision support tool for community-based oncologists. The Pathways system is currently used by Division oncologists and clinical investigators and UPMC CancerCenter medical oncologists to identify available clinical trials and the best available cancer treatment for each patient, based on the individual patient’s type and stage of cancer. Nearly 90% of the common solid tumors and hematologic malignancies are represented in this Pathways system, and the registry of open clinical trials that are actively accruing patients is continuously updated.
Division of Hematology/Oncology
UPMC Cancer Pavilion
5150 Centre Avenue, 5th floor
Pittsburgh, PA 15232
412-648-6575 | Email Us
Hillman Cancer Center
5115 Centre Avenue
Pittsburgh, PA 15232